---
title: 'AnnotateMissense: Genome-Wide Variant Scoring'
url: https://www.emergentmind.com/topics/annotatemissense
type: topic
---

# AnnotateMissense: Genome-Wide Variant Scoring

Searching arXiv for the primary paper and closely related missense-prediction work cited in the provided material.
AnnotateMissense is a genome-wide missense variant annotation, feature-integration, benchmarking, and prediction framework developed to score the pathogenicity of missense single-nucleotide variants across the human hg38/GRCh38 genome [2605.24520]. It begins with a genome-wide missense catalog, enriches each variant with a large integrated annotation set, trains supervised classifiers on ClinVar-labeled missense variants, benchmarks multiple machine-learning and deep-learning models under controlled feature configurations, performs circularity-controlled ablations and temporal validation, and then produces pathogenicity scores and binary prediction labels for 90,643,830 hg38 missense variants [2605.24520]. The framework is best understood as a large-scale integrative meta-framework rather than as a single de novo biological model, because it combines transcript and gene annotation, conservation, population frequency, prior pathogenicity predictors, AlphaMissense, ESM-derived features, and engineered amino-acid, codon, and nucleotide-context features within supervised predictive models [2605.24520].

## 1. Scope, problem formulation, and released resource

AnnotateMissense addresses the problem of predicting whether a missense variant is likely pathogenic or benign [2605.24520]. The framework is framed around the observation that missense pathogenicity depends on heterogeneous evidence from population frequency, evolutionary conservation, transcript context, amino acid substitution severity, prior pathogenicity predictors, and protein-language-model-derived features [2605.24520]. Its operational target is binary pathogenic-versus-benign classification for missense single-nucleotide variants, with training labels derived from ClinVar after harmonization of pathogenic or likely pathogenic as the positive class and benign or likely benign as the negative class, while uncertain, conflicting, ambiguous, and unsupported categories are excluded [2605.24520].

The framework has two distinct but connected roles. First, it is an annotation and benchmarking system built on a curated ClinVar-labeled benchmark of 132,714 missense variants, comprising 76,804 pathogenic or likely pathogenic variants and 55,910 benign or likely benign variants [2605.24520]. Second, it is a genome-wide prediction resource that scores 90,643,830 hg38 missense single-nucleotide variants derived from dbNSFP v5.1 through the CAGI7 Annotate-All-Missense challenge input [2605.24520]. The released output consists of pathogenicity scores and binary predictions for this full missense universe [2605.24520].

This design places AnnotateMissense within a broader class of missense interpretation systems that integrate complementary evidence sources. Related work has described integration over strong pretrained predictors such as GPN-MSA, ESM1b, and AlphaMissense for difficult missense classification [2411.05055], report-centric platforms combining missense prediction with structural and literature evidence [2104.01033], protein-feature delta models derived from fine-tuned ESM2 [2410.10919], and structure-centered graph models such as ALPHAGMUT [2406.09159]. AnnotateMissense differs from those systems in being explicitly genome-wide, benchmark-oriented, and centered on a very large integrated annotation stack [2605.24520].

## 2. Data sources and annotation architecture

The starting point for AnnotateMissense was the CAGI7 Annotate-All-Missense challenge input, derived from dbNSFP v5.1, provided as chromosome-divided files aligned to hg38/GRCh38, and containing 90,643,830 missense single nucleotide variants [2605.24520]. The annotation workflow converted each chromosome-level file into ANNOVAR-compatible input, ran ANNOVAR gene-based protocols, merged outputs chromosome-wise, augmented the merged tables with amino-acid substitution information and transcript-level descriptors from dbNSFP, and then added AlphaMissense scores, ESM-derived scores, and engineered biological variables [2605.24520].

Gene and transcript annotation was performed with ANNOVAR using RefSeq, Ensembl, UCSC Known Gene, CCDS, and GENCODE, together with exon function annotations and transcript consequence annotations [2605.24520]. Population-frequency variables included gnomAD, ExAC, 1000 Genomes, population-specific allele frequencies, and allele rarity metrics [2605.24520]. Conservation variables included PhyloP, PhastCons, GERP++, SiPhy, and related vertebrate and mammalian conservation features; examples explicitly named in the paper include `phyloP100way_vertebrate_dbnsfp42c` and `GERP++_RS_rankscore` [2605.24520].

A central property of the framework is the breadth of prior pathogenicity predictors included in the full benchmark. These predictors include SIFT, SIFT4G, PolyPhen-2, CADD, DANN, REVEL, MetaSVM, MetaLR, MetaRNN, BayesDel, ClinPred, FATHMM, LRT, PROVEAN, DEOGEN2, MVP, VEST4, MPC, PrimateAI, MutationTaster, and MutationAssessor [2605.24520]. The AI-derived components explicitly added were AlphaMissense and ESM-derived missense effect predictions [2605.24520]. The engineered biological feature layer included BLOSUM62 scores, amino-acid physicochemical changes, codon composition, CpG context, transition/transversion status, consensus voting features, interaction features, codon bias, nucleotide context, amino-acid severity classes, and protein-context engineered features; representative engineered variables reported in feature-importance analyses include `blosum62_score`, `refcodon_merged`, `blosum_non_conservative`, `alt_charged`, `aa_structural_impact`, and `codon_gc_content` [2605.24520].

Preprocessing and filtering were fold-specific during supervised benchmarking, with shared training and test features retained within each fold, missing values filled with zero, and inputs standardized using `StandardScaler` fitted on the training split and applied to the test split [2605.24520]. Automatic filtering removed features with excessive missingness, constant features, genomic coordinate fields, and ClinVar-derived annotations likely to leak target labels [2605.24520]. For genome-wide prediction, the supplement reports 334 candidate features evaluated across 25 chromosome-level files, 207 features retained for modelling, 127 excluded, 151 retained numeric features, and 56 retained categorical features, with average missingness among retained features of 14.6% and median missingness of 16.4% [2605.24520].

## 3. Feature configurations and model families

The benchmark is organized around several explicitly defined feature configurations [2605.24520]. The central configuration is Dataset 2, the full 303-feature benchmark matrix, which includes computational pathogenicity predictors, conservation scores, functional annotations, population-frequency variables, categorical variables, raw biological sequence variables, unified prediction mapping, amino-acid property features, codon features, nucleotide substitution features, consensus-voting features, interaction features, AlphaMissense, and ESM-derived features [2605.24520]. The remaining configurations probe restricted or circularity-controlled versions of this integrated representation.

Dataset 3 is a naive 41-feature matrix retaining conservation scores, functional annotations, and categorical variables [2605.24520]. Dataset 4 is a location-oriented 56-feature matrix retaining functional annotations, categorical variables, raw biological sequence variables, and derived biological variables such as BLOSUM62, amino-acid property changes, codon composition features, and nucleotide substitution features [2605.24520]. Dataset 5, NoPriorPredictors, removes computational pathogenicity predictor scores and population-frequency metrics while retaining conservation, functional and transcript annotations, categorical variables, and engineered biological features [2605.24520]. Dataset 6, NoClinicalFeatures, more conservatively excludes prior pathogenicity predictors, BayesDel allele-frequency scores, AlphaMissense, ESM-derived scores, MetaRNN, and ClinPred [2605.24520]. Dataset 7, NoAlphaMissenseESM, excludes only AlphaMissense and ESM-derived features [2605.24520]. Dataset 8, EngineeredBiologicalOnly, retains only engineered sequence-derived biological features including BLOSUM62, amino-acid physicochemical changes, codon composition, CpG context, codon bias, transition/transversion status, and nucleotide context [2605.24520].

The study evaluates both classical machine-learning and deep-learning models [2605.24520]. XGBoost was used with `n_estimators = 200`, `max_depth = 8`, `learning_rate = 0.1`, `subsample = 0.8`, `colsample = 0.8`, and fold-specific `scale_pos_weight` in the primary benchmark, while the final genome-wide model used `max_depth = 6`, `subsample = 0.9`, `colsample_bytree = 0.9`, `reg_alpha = 0.1`, `reg_lambda = 1.0`, `random_state = 42`, and log loss as evaluation metric [2605.24520]. Random Forest used 200 trees, max depth 15, min split 5, min leaf 2, `max_features = sqrt`, bootstrap aggregation, out-of-bag scoring, and balanced class weights [2605.24520]. FLAML AutoML optimized ROC-AUC within a 600-second time budget per fold over XGBoost, Random Forest, LightGBM, and Extra Trees [2605.24520]. TabNet used `n_d = 64`, `n_a = 64`, `n_steps = 7`, `gamma = 1.3`, `lambda_sparse = 1e-3`, Adam, entmax masking, and step-wise learning-rate scheduling [2605.24520]. The PyTorch DNN used four hidden layers of 512, 256, 128, and 64 units with batch normalization, dropout 0.4, 0.3, 0.2, and 0.1, Adam, and early stopping, while the TensorFlow DNN used dense 512–256–128–64 layers with batch normalization, dropout, Adam, binary cross-entropy loss, and internal validation-based early stopping [2605.24520].

The main benchmark employed five-fold stratified cross-validation, with benign encoded as 0 and pathogenic encoded as 1, Matthews correlation coefficient as the primary metric, and ROC-AUC as the secondary metric [2605.24520]. The choice of MCC is consistent with the paper’s focus on balanced binary discrimination across feature ablations and model families [2605.24520].

## 4. Benchmark performance and temporal validation

On the full 303-feature Dataset 2, XGBoost was the best-performing model overall, reaching ROC-AUC \(0.99497 \pm 0.00039\) and MCC \(0.94108 \pm 0.00198\), with a 95% confidence interval for MCC of \([0.93862, 0.94354]\) [2605.24520]. FLAML AutoML was close behind with ROC-AUC \(0.99486 \pm 0.00044\) and MCC \(0.94024 \pm 0.00180\), followed by Random Forest, TabNet, PyTorch DNN, and TensorFlow DNN, all with ROC-AUC above 0.992 and MCC above 0.931 on Dataset 2 [2605.24520]. These results identify the full integrated feature space, rather than any single model architecture, as the dominant source of benchmark performance [2605.24520].

Performance dropped sharply on reduced feature sets. On Dataset 3, the naive 41-feature configuration, the best MCC was \(0.49889 \pm 0.00763\) with FLAML AutoML and ROC-AUC was \(0.82752 \pm 0.00382\) [2605.24520]. On Dataset 4, the location-oriented 56-feature configuration, the best MCC was \(0.51125 \pm 0.00743\) with Random Forest and ROC-AUC was \(0.83115 \pm 0.00273\) [2605.24520]. Dataset 8, EngineeredBiologicalOnly, produced very similar performance, with the best MCC at \(0.51204 \pm 0.00650\) using Random Forest and ROC-AUC \(0.83107 \pm 0.00267\) [2605.24520]. The paper explicitly interprets these results as showing that engineered sequence and protein-context features contain useful signal but are insufficient on their own [2605.24520].

The framework was also compared with established pathogenicity predictors across 135,512 missense variants [2605.24520]. The Dataset 2 XGBoost model reached Pearson correlation 0.983, Spearman correlation 0.853, MCC 0.981, and accuracy 0.991 against ClinVar binary labels [2605.24520]. Examples of comparator values include MetaRNN with MCC 0.883 and accuracy 0.942, BayesDel_addAF with MCC 0.818 and accuracy 0.908, PROVEAN with MCC 0.615 and accuracy 0.806, PolyPhen-2 HVAR with MCC 0.582 and accuracy 0.785, SIFT4G with MCC 0.556 and accuracy 0.774, AlphaMissense with MCC 0.420 and accuracy 0.658, REVEL with MCC 0.426 and accuracy 0.670, and CADD with MCC 0.205 and accuracy 0.476 [2605.24520]. The paper cautions that such high concordance with ClinVar should be interpreted in light of possible evidence overlap and circularity [2605.24520].

Temporal validation was performed by parsing a newer ClinVar `variant_summary.txt`, restricting to GRCh38 SNVs, retaining only pathogenic and benign labels, removing variants already present in the older annotation-derived set, and evaluating the final categorical predictions joined by chromosome, VCF position, reference allele, and alternate allele [2605.24520]. From 4,129,645 newer ClinVar GRCh38 SNVs, the authors derived 1,459,305 newly observed strict pathogenic or benign variants, of which 298,353 had AnnotateMissense categorical predictions [2605.24520]. On this temporal validation, AnnotateMissense achieved MCC 0.7613, accuracy 0.8798, sensitivity 0.9070, specificity 0.8563, precision 0.8453, and F1-score 0.8750 [2605.24520]. The paper explicitly states that this is temporal concordance with ClinVar rather than independent clinical validation [2605.24520].

## 5. Circularity-controlled ablations and methodological interpretation

The ablation analyses are among the most consequential aspects of AnnotateMissense because they quantify how much benchmark performance depends on potentially overlapping evidence sources [2605.24520]. When prior pathogenicity predictors and population-frequency metrics were removed in Dataset 5, XGBoost dropped from MCC 0.94108 on Dataset 2 to MCC 0.71977, with ROC-AUC decreasing from 0.99497 to 0.93979 [2605.24520]. Dataset 6, which also excluded broader clinically overlapping features such as BayesDel allele-frequency scores, AlphaMissense, ESM-derived scores, MetaRNN, and ClinPred, produced nearly identical performance to Dataset 5; for XGBoost, MCC was 0.71906 and ROC-AUC was 0.93977 [2605.24520]. The paper interprets this as showing that once prior predictors and population-frequency information are removed, excluding the additional clinically overlapping tools does not cause a much larger drop [2605.24520].

By contrast, removing only AlphaMissense and ESM-derived features in Dataset 7 had minimal effect [2605.24520]. For XGBoost, MCC changed only from 0.94108 on Dataset 2 to 0.94029 on Dataset 7, while ROC-AUC changed from 0.99497 to 0.99470 [2605.24520]. The paper therefore concludes that AlphaMissense and ESM contribute little independent gain once the broader feature space is already present [2605.24520]. This sharply distinguishes AnnotateMissense from integration studies in which AlphaMissense-like or ESM-like signals are more central. For example, an integration study over GPN-MSA, ESM1b, and AlphaMissense reported that adding AlphaMissense materially boosted downstream performance on hard ProteinGym and ClinVar-linked missense subsets [2411.05055]. A plausible implication is that the marginal value of AlphaMissense- and ESM-derived signals depends strongly on the rest of the feature stack rather than being invariant across frameworks.

These ablations also clarify the meaning of AnnotateMissense as a predictor. The paper states that the full model functions substantially as an integrative meta-predictor rather than purely as a de novo biological predictor [2605.24520]. This characterization is important when comparing it with platforms such as Helix, which explicitly avoid using predictions from other classifiers as features and do not use minor allele frequency as a feature [2104.01033], or with sequence-centered models such as MutFormer, whose sequence-only form is intended to provide a relatively independent learned sequence prior [2110.14746]. AnnotateMissense instead demonstrates the performance obtainable when many established signals are aggregated at scale [2605.24520].

The framework’s biological use-case analysis on ClinVar missense VUS adds a secondary interpretive layer. Applied to 49,990 ClinVar missense VUS and compared against gnomAD v2.1.1 missense constraint Z-score (`mis_z`), AnnotateMissense assigned higher scores to variants in more missense-intolerant genes: mean 0.631 and median 0.748 for `mis_z > 3`, mean 0.600 and median 0.705 for \(0 \leq \text{mis\_z} \leq 3\), and mean 0.548 and median 0.614 for `mis_z < 0` [2605.24520]. The proportion of variants with score \(> 0.9\) was 37.4% in intolerant genes, 34.0% in intermediate genes, and 31.5% in tolerant genes, with Mann–Whitney \(p = 1.45 \times 10^{-55}\) for intolerant versus tolerant and \(p = 2.43 \times 10^{-13}\) for intolerant versus intermediate [2605.24520]. The paper interprets this as biologically consistent with stronger predicted pathogenicity in genes under greater missense constraint [2605.24520].

## 6. Outputs, intended use, and limitations

For genome-wide inference, the final model was XGBoost trained on merged chromosome feature files after retaining only variants with benign or pathogenic `CLNSIG`, excluding VUS and unknown labels, applying a stratified 80:20 train/test split, and using SMOTE only on the training data [2605.24520]. The resulting classifier generated a continuous pathogenicity score and a binary label for each missense variant in the 90,643,830-variant hg38 universe [2605.24520]. Binary predictions are typically thresholded at 0.5, so score \(\geq 0.5\) corresponds to pathogenic or damaging and score \(< 0.5\) corresponds to benign or tolerated [2605.24520]. The outputs were released through a GitHub repository and a Zenodo deposition that includes genome-wide prediction output and a DuckDB database with selected annotations and predictions [2605.24520].

The intended use is research prioritization, benchmarking, and variant triage, with the paper explicitly stating that AnnotateMissense should not be interpreted as a standalone clinical classification system [2605.24520]. This positioning aligns with a wider pattern in missense interpretation tools. Helix is likewise presented as decision support rather than autonomous clinical interpretation [2104.01033]. Protein-feature delta models based on fine-tuned ESM2 are described as best used as explanatory annotation layers or PM1-support modules rather than as standalone clinical pathogenicity predictors [2410.10919]. Structure-centered systems such as ALPHAGMUT are described as particularly suitable as structural annotation modules or ensemble components when good 3D structures are available [2406.09159]. AnnotateMissense belongs to this decision-support landscape but is distinguished by its genome-wide scope and explicit emphasis on benchmarking [2605.24520].

The paper is unusually explicit about its limitations [2605.24520]. First, ClinVar-based benchmarking may inflate performance because many included predictors were trained on ClinVar, HGMD, or overlapping databases, so shared prior knowledge may contribute to apparent predictive strength [2605.24520]. Second, the ablations show that much of the high benchmark performance depends on prior pathogenicity predictors and population-frequency information, confirming that the full model behaves substantially as an integrative meta-predictor [2605.24520]. Third, temporal validation is described as temporal concordance with ClinVar rather than true external clinical validation [2605.24520]. Fourth, although direct ClinVar fields such as `CLNDN`, `CLNREVSTAT`, `CLNDISDB`, and `CLNALLELEID` were removed, residual indirect leakage remains possible through external features trained on overlapping sources [2605.24520]. A further implementation caveat noted in the supplement is that TensorFlow DNN results are omitted for Datasets 5–8 because of a file caching issue identified post hoc [2605.24520].

In methodological terms, AnnotateMissense shows that very high ClinVar-concordant performance can be obtained from a large integrated annotation stack, but it also shows that such performance is strongly contingent on previously learned predictors and population-frequency evidence [2605.24520]. This suggests that the framework is most informative when interpreted as a scalable, queryable, and benchmarked aggregation layer over heterogeneous missense evidence rather than as a self-sufficient mechanistic model.

Source: https://www.emergentmind.com/topics/annotatemissense